🌬️ RespiratoryInjectable Solution

    Synagis

    Palivizumab

    A monoclonal antibody used to prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients, including premature infants and those with bronchopulmonary dysplasia or congenital heart disease.

    Form

    Injectable Solution

    Uses

    3

    Side effects

    3

    Category

    Respiratory

    01

    What is Synagis used for?

    • Prevention of RSV lower respiratory tract disease in premature infants 35 weeks gestational age or younger.
    • Prevention of RSV disease in pediatric patients with bronchopulmonary dysplasia requiring medical treatment.
    • Prevention of RSV disease in pediatric patients with hemodynamically significant congenital heart disease.
    02

    Palivizumab side effects

    Common side effects of Palivizumab include:

    Fever
    Rash
    Injection site reactions
    CommonModerateLess common
    03

    Palivizumab warnings & precautions

    • Risk of anaphylaxis and severe hypersensitivity reactions; permanently discontinue if anaphylaxis occurs.
    • Monitor for acute hypersensitivity reactions with each dose.

    Loading FDA data…

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Synagis in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.